Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine

D. Kanduc, Y. Shoenfeld,

2021

https://doi.org/10.1007/s12026-020-09152-6

Цитирование

Об авторах

D. Kanduc
Department of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, Via Orabona 4, Bari, 70125, Italy
Y. Shoenfeld
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University School of Medicine, Tel-Hashomer, Israel

Название журнала

Том

Выпуск

Страницы

Ключевые слова

proteome; Severe acute respiratory syndrome coronavirus 2 spike glycoprotein; unclassified drug; vaccine; virus glycoprotein; coronavirus spike glycoprotein; COVID-19 vaccine; peptide; proteome; spike protein, SARS-CoV-2; virus antigen; virus vaccine; Article; mammal; molecular mimicry; nonhuman; peptide analysis; priority journal; protein determination; proteomics; sequence analysis; Severe acute respiratory syndrome coronavirus 2; species comparison; age; animal; animal model; Betacoronavirus; bovine; cat; chemistry; Coronavirus infection; cross reaction; drug development; human; immunology; Leporidae; molecular mimicry; mouse; pandemic; pathogenicity; pig; virology; virus pneumonia; Age Factors; Animals; Antigens, Viral; Betacoronavirus; Cats; Cattle; Coronavirus Infections; Cross Reactions; Drug Development; Humans; Mice; Models, Animal; Molecular Mimicry; Pandemics; Peptides; Pneumonia, Viral; Proteome; Rabbits; Spike Glycoprotein, Coronavirus; Swine; Viral Vaccines

Издатель

Тип документа

Источник